|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,531 GBX | +0.33% |
|
-4.30% | +5.51% |
| 05:57am | Sembcorp Inks Power Deals with GSK for Singapore Manufacturing Sites; Shares Down 3% | MT |
| Jun. 27 | Health Care Stocks Fall With Broad Market -- Health Care Roundup | DJ |
GSK plc:
* GSK PLC - OMJJARA APPROVED IN JAPAN FOR MYELOFIBROSIS
* GSK - GSK'S OMJJARA (MOMELOTINIB) APPROVED IN JAPAN FOR TREATMENT OF MYELOFIBROSIS Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +5.51% | 78.69B | |
| +55.95% | 819B | |
| -6.98% | 351B | |
| +19.08% | 329B | |
| +9.05% | 298B | |
| +17.04% | 242B | |
| +2.25% | 225B | |
| +13.23% | 217B | |
| +8.91% | 168B | |
| -3.44% | 158B |
GSK PLC 
